Extracellular vesicles derived from

THP-1 macrophages Talaromyces marneffei extracellular vesicles (EVs) fungal melanin inflammatory response macrophage (plasticity) polarization yeast mannoprotein

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 23 03 2023
accepted: 08 06 2023
medline: 18 7 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: epublish

Résumé

Pathogenic eukaryotes including fungi release extracellular vesicles (EVs) which are composed of a variety of bioactive components, including peptides, nucleic acids, polysaccharides, and membrane lipids. EVs contain virulence-associated molecules suggesting a crucial role of these structures in disease pathogenesis. EVs derived from the pathogenic yeast phase of

Identifiants

pubmed: 37457708
doi: 10.3389/fimmu.2023.1192326
pmc: PMC10339390
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1192326

Informations de copyright

Copyright © 2023 Pruksaphon, Amsri, Thammasit, Nosanchuk and Youngchim.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eukaryot Cell. 2007 Jan;6(1):48-59
pubmed: 17114598
Cell Microbiol. 2008 Aug;10(8):1695-710
pubmed: 18419773
Front Microbiol. 2018 Oct 02;9:2286
pubmed: 30333803
FEBS J. 2013 Dec;280(24):6613-26
pubmed: 24128375
Microbes Infect. 2018 Oct - Nov;20(9-10):501-504
pubmed: 29471026
Curr Opin Microbiol. 2019 Dec;52:90-99
pubmed: 31280026
mSphere. 2016 Jun 29;1(4):
pubmed: 27390779
Mycoses. 2021 Oct;64(10):1170-1176
pubmed: 34110649
Cell Microbiol. 2015 Mar;17(3):389-407
pubmed: 25287304
Sci Rep. 2016 Oct 24;6:35867
pubmed: 27775058
Antimicrob Agents Chemother. 2006 Nov;50(11):3519-28
pubmed: 17065617
Front Microbiol. 2015 Dec 22;6:1463
pubmed: 26733993
mSphere. 2020 May 6;5(3):
pubmed: 32376699
Mol Immunol. 2004 Feb;40(12):869-76
pubmed: 14698225
PLoS Pathog. 2009 Nov;5(11):e1000678
pubmed: 19956672
FEBS J. 2010 Sep;277(18):3750-8
pubmed: 20718860
Emerg Microbes Infect. 2016 Mar 09;5:e19
pubmed: 26956447
Diagnostics (Basel). 2021 Apr 23;11(5):
pubmed: 33922698
Microb Pathog. 2021 Oct;159:105158
pubmed: 34454025
Trends Cell Biol. 2021 Mar;31(3):179-196
pubmed: 33293167
Future Sci OA. 2017 Jun 30;3(3):FSO215
pubmed: 28884011
Nat Prod Rep. 2010 Jun;27(6):869-86
pubmed: 20411198
Sci Rep. 2020 Dec 3;10(1):21169
pubmed: 33273617
J Fungi (Basel). 2022 Mar 19;8(3):
pubmed: 35330320
Virulence. 2019 Dec;10(1):277-291
pubmed: 30880596
PLoS Negl Trop Dis. 2016 Aug 25;10(8):e0004907
pubmed: 27560160
Clin Diagn Lab Immunol. 2001 Nov;8(6):1240-7
pubmed: 11687470
PLoS One. 2013;8(1):e54845
pubmed: 23382985
Lancet Glob Health. 2021 Nov;9(11):e1618-e1622
pubmed: 34678201
N Engl J Med. 2000 Jul 6;343(1):37-49
pubmed: 10882768
Pathogens. 2022 Dec 02;11(12):
pubmed: 36558799
PLoS One. 2011 Apr 14;6(4):e18564
pubmed: 21533172
PLoS Negl Trop Dis. 2023 May 4;17(5):e0011281
pubmed: 37141335
PLoS Pathog. 2015 Dec 03;11(12):e1005240
pubmed: 26633018
Mol Microbiol. 2018 Oct;110(1):11-15
pubmed: 30079549
PLoS One. 2014 Mar 19;9(3):e92610
pubmed: 24647795
Sci Rep. 2021 Jan 27;11(1):2334
pubmed: 33504839
J Fungi (Basel). 2022 Feb 19;8(2):
pubmed: 35205954
Cold Spring Harb Perspect Med. 2014 Nov 10;5(7):a019661
pubmed: 25384769
J Clin Microbiol. 1998 Apr;36(4):949-54
pubmed: 9542914
Infect Immun. 2010 Apr;78(4):1601-9
pubmed: 20145096
Front Immunol. 2018 Oct 09;9:2343
pubmed: 30356863
PLoS One. 2008 Jun 18;3(6):e2461
pubmed: 18560543
J Fungi (Basel). 2021 Sep 24;7(10):
pubmed: 34682218
J Fungi (Basel). 2021 Mar 31;7(4):
pubmed: 33807336
Antonie Van Leeuwenhoek. 2014 Nov;106(5):1011-20
pubmed: 25227777
EMBO Rep. 2015 Jan;16(1):24-43
pubmed: 25488940
Virulence. 2016 Aug 17;7(6):702-17
pubmed: 27224737
Eukaryot Cell. 2011 Mar;10(3):343-51
pubmed: 21216942
Clin Microbiol Rev. 2023 Mar 23;36(1):e0005122
pubmed: 36648228
Virulence. 2021 Dec;12(1):1997-2012
pubmed: 34339354
Front Microbiol. 2021 Jan 08;11:603183
pubmed: 33488545
Clin Microbiol Rev. 2006 Jan;19(1):95-110
pubmed: 16418525
Microbiology (Reading). 2009 Dec;155(Pt 12):3860-3867
pubmed: 19729402
Microbiology (Reading). 2005 Jan;151(Pt 1):291-299
pubmed: 15632446

Auteurs

Kritsada Pruksaphon (K)

Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Artid Amsri (A)

Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Patcharin Thammasit (P)

Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Joshua D Nosanchuk (JD)

Department of Medicine (Division of Infectious Diseases) and Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, United States.

Sirida Youngchim (S)

Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH